InvestSMART

BlinkLab Limited (ASX: BB1) - Announcements

Current share price for BB1 : $0.585 0.005 (0.85%)+

ASX company news and announcements for BlinkLab Limited (BB1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BlinkLab Limited (BB1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BlinkLab Limited (BB1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BlinkLab Limited (BB1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$103 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2026 9:08AM $0.630 $0.585 fallen by 7.14%
$103 Commencement of Nationwide Autism Screening in Morocco 22 Oct 2026 9:39AM $0.620 $0.585 fallen by 5.65%
$103 BB1 to Present at Simons Foundation and ThinkEquity in NYC 13 Oct 2026 9:13AM $0.620 $0.585 fallen by 5.65%
$103 BB1 to Present at Spark Plus Aussie Equities Day Singapore 9 Oct 2026 9:38AM $0.645 $0.585 fallen by 9.30%
$103 BB1 to Present at NSSpain - Apple Developer Conference 17 Sep 2026 8:51AM $0.680 $0.585 fallen by 13.97%
$103 Change of Director's Interest Notice x3 11 Sep 2026 2:57PM $0.700 $0.585 fallen by 16.43%
$103 Section 708A Notice 10 Sep 2026 7:10PM $0.730 $0.585 fallen by 19.86%
$103 Application for quotation of securities - BB1 10 Sep 2026 7:07PM $0.730 $0.585 fallen by 19.86%
$103 Initial Director's Interest Notice 10 Sep 2026 8:30AM $0.765 $0.585 fallen by 23.53%
$103 Final Director's Interest Notice 10 Sep 2026 8:29AM $0.765 $0.585 fallen by 23.53%
$103 Notification regarding unquoted securities - BB1 10 Sep 2026 8:29AM $0.765 $0.585 fallen by 23.53%
$103 Former Apple Health Clinical Lead Appointed to the Board 8 Sep 2026 9:05AM $0.770 $0.585 fallen by 24.03%
$103 Results of AGM 7 Sep 2026 5:02PM $0.770 $0.585 fallen by 24.03%
$103 Corporate Presentation Update 1 Sep 2026 8:56AM $0.765 $0.585 fallen by 23.53%
$103 Resignation and Appointment of Auditor 12 Aug 2026 2:35PM $0.700 $0.585 fallen by 16.43%
$103 Investor Webinar - Positive European ADHD Study Results 5 Aug 2026 10:04AM $0.750 $0.585 fallen by 22%
$103 European ADHD Study Delivers Positive Results 5 Aug 2026 9:15AM $0.675 $0.585 fallen by 13.33%
$103 Letter to Shareholders & Proxy Form 4 Aug 2026 4:55PM $0.675 $0.585 fallen by 13.33%
$103 Notice of Annual General Meeting & Proxy Form 4 Aug 2026 4:54PM $0.675 $0.585 fallen by 13.33%
$103 Trading Halt 3 Aug 2026 9:24AM $0.675 $0.585 fallen by 13.33%
$103 Appendix 4G & Corporate Governance Statement 31 Jul 2026 2:28PM $0.685 $0.585 fallen by 14.60%
$103 2026 Annual Report & Appendix 4E 31 Jul 2026 2:26PM $0.685 $0.585 fallen by 14.60%
$103 BlinkLab to Present at TechKnow Invest Roadshow 27 Jul 2026 9:58AM $0.590 $0.585 fallen by 0.85%
$103 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2026 9:08AM $0.590 $0.585 fallen by 0.85%
$103 Change of Director's Interest Notice x4 14 Jul 2026 4:22PM $0.620 $0.585 fallen by 5.65%

1 - 25 of 199 results

Page 1 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.